ARTICLE | Product Development
Gene editing: designing therapies for market access
In vivo stem cell editing and diversification of genomic databases are top research priorities to promote equitable access
March 14, 2023 10:25 PM UTC
An access problem looms for gene editing therapies, and it goes beyond prohibitive pricing and complex clinical care requirements. Achieving equitable global access to the curative technology will require stepping back to build equity considerations into the scientific foundation of drug design.
Democratizing gene editing therapies was a major theme that ran throughout last week’s Third International Summit on Genome Editing...